Raimundo Leon, MD
Anesthesiology · Las Vegas, NVNPI 1508905134
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Abbott at 25.6% of the total. Reporting peaked in 2021 at $452 and has fallen 92.6% since, to $34 in 2025.
Across 19 payments — averaging $44.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$216
- Celularity Inc.$137
- Relievant Medsystems, Inc.$113
- Nevro Corp.$99
- Boston Scientific$94
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$55
- plus $131 from 5 others
What the payments were for
- Food & beverage$845100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 3 | $216 |
| Celularity Inc. | 1 | $137 |
| Relievant Medsystems, Inc. | 1 | $113 |
| Nevro Corp. | 4 | $99 |
| Boston Scientific | 2 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $55 |
| Nalu Medical, Inc. | 1 | $40 |
| Protega Pharmaceutials Inc | 2 | $34 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $33 |
| Almatica Pharma LLC | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$226
- Proclaim IPG$127
How this compares
$845 in reported general payments places this provider in the 85th percentile of 457 anesthesiology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 263 | $5,594 |
| Oxycodone Hcl | 147 | $5,337 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 163 | $4,384 |
| Morphine Sulfate ErMorphine Sulfate | 31 | $906 |
| Tizanidine Hcl | 44 | $573 |
| Methadone Hcl | 22 | $444 |
| Ibuprofen | 47 | $422 |
| Gabapentin | 41 | $336 |
| Tramadol Hcl | 37 | $259 |
| Cyclobenzaprine Hcl | 20 | $130 |
| Meloxicam | 52 | $98 |
| Methylprednisolone | 18 | $95 |
| Baclofen | 17 | $89 |
| Celecoxib | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Las Vegas
- Edward LizanoLas Vegas$1.2M
- Steven EvansLas Vegas$52K
- Yi McWhorterLas Vegas$23K
- Khuram KhanLas Vegas$23K
- Stephanie DavidsonLas Vegas$13K
- Mauricio NinoLas Vegas$12K
- Christopher AhnLas Vegas$6K
- Balazs MakaiLas Vegas$6K
- Ziad SawiLas Vegas$5K
- Cherie ManyLas Vegas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.